Management

Diede van den Ouden

CEO

Diede van den Ouden has been a professional investor since 2008 with a proven track record as investor in listed company for many years. His knowledge and experience enable him to manage the constantly changing market conditions well. Since September 2024 Diede has served as CEO and President of Tonner Drones SA, listed on Euronext Growth Paris. From December 2022 to January 2025, he was CEO of Lavide Holding NV where he successfully led a reorganization and ensured a good future for this company by finding the right partner in Haerlem Capital. As an investor, he regularly played an advisory role to the management of other listed companies.

Jarl Ulf Jungnelius, MD, PhD

CMO

Jarl Ulf Jungnelius, MD, PhD joined the company as Chief Medical Officer in February 2017. He is an oncologist with more than 25 years of clinical and research experience at both large pharmaceutical companies and academic organizations.

Jarl Ulf was CEO of Isofol Medical AB. He also serves on boards of Biovica International, CarpoNovum, Oncopeptides and Ryvu Therapeutics. Jarl Ulf held important responsibilities in the clinical development of several successful oncology drugs, including Abraxane^®, Gemzar^®, Alimta^® and Revlimid^®. He worked at Celgene from 2007 to 2014 where he served as Vice President of Clinical Research and Development, Solid Tumors. Prior to that post Jarl Ulf held leadership positions at Takeda, Pfizer, Eli Lilly & Company and VAXIMM, where he was responsible for clinical development of oncology programs as well as being involved in business development.

He received both a Bachelor of Science degree and his MD from the Karolinska Institute in Stockholm Sweden.